Liquid Biopsy Collection Study

Last updated: December 3, 2024
Sponsor: University of Central Florida
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT06068348
STUDY00003221
  • Ages 18-80
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose of this study is to develop a liquid biopsy approach for detection of circulating tumor cells (CTC) that could be used in place of the more invasive and potentially risky methods of tissue biopsy. The aims of the project are: (a) determine whether the Chaperonin-Containing TCP-1 (CCT) chaperonin can used to identify rare cancer cells in blood, and (b) establish whether the cancer cells detected using the CCT chaperonin for identification have invasive or metastatic potential.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Male or female

  • Age greater than or equal to 18 and less than or equal to 80 years.

Exclusion

Exclusion Criteria:

  • Adults unable to give informed consent

  • Individuals who are not yet adults (infants, children, teenagers; under the age of

  • Individuals who weigh less than 110 lbs (as standard clinically advised to not giveblood)

  • Pregnant women (due to hormonal changes in blood)

  • Prisoners

  • Persons reporting a current microbial (bacterial, viral, or fungal) infections

  • Persons reporting that they are current taking antibiotic medications

  • Persons with body temperatures above 99oF (indicating a fever)

Study Design

Total Participants: 60
Study Start date:
October 07, 2021
Estimated Completion Date:
October 31, 2025

Connect with a study center

  • University of Central Florida

    Orlando, Florida 32816
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.